S.D. Admin. R. 44:90:09:01

Current through Register Vol. 51, page 67, December 16, 2024

Section 44:90:09:01 - Mandatory testing prior to transfer for retail sale

A medical cannabis establishment must test every batch of cannabis or cannabis product intended for consumption prior to transfer for retail sale in final form prior to transfer. Any alterations made by a medical cannabis establishment after receipt of cannabis or cannabis product results in the creation of a new final form.

The following tests are required for cannabis and cannabis products:

(1) Potency testing for THC content and, if so labeled, CBD content. The allowed variance for THC content may not exceed plus or minus ten percent; and

(2) Microbials listed in § 44:90:05:10(3);

(3) Mycotoxins listed in § 44:90:05:10(2);

(4) Metals listed in § 44:90:05:10(4) and 44:90:07:03;

(5) Pesticides listed in § 44:90:05:10(1); and

(6) Solvents listed in § 44:90:07:03.

S.D. Admin. R. 44:90:09:01

48 SDR 040, effective 10/5/2021; 49 SDR 009, effective 8/8/2022; 50 SDR 062, effective 11/27/2023

General Authority: SDCL 34-20G-72(5)(d)(e)(l).

Law Implemented: SDCL 34-20G-72.